Pharmacological Therapy for Ventricular Arrhythmias: A State-of-the Art Review.


Journal

Heart, lung & circulation
ISSN: 1444-2892
Titre abrégé: Heart Lung Circ
Pays: Australia
ID NLM: 100963739

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 09 04 2018
revised: 28 09 2018
accepted: 01 10 2018
pubmed: 6 11 2018
medline: 17 1 2019
entrez: 6 11 2018
Statut: ppublish

Résumé

While implantable cardioverter defibrillators decrease mortality in high risk groups of patients who have ventricular arrhythmias, antiarrhythmic drugs are still required to reduce the burden of both benign and life-threatening arrhythmias. This review will address the available medical therapy for ventricular arrhythmias in Australia and their use in different clinical situations.

Identifiants

pubmed: 30392983
pii: S1443-9506(18)31943-7
doi: 10.1016/j.hlc.2018.10.002
pii:
doi:

Substances chimiques

Anti-Arrhythmia Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

49-56

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Auteurs

Karin K M Chia (KKM)

Department of Cardiology, Royal North Shore Hospital Sydney, Sydney, NSW, Australia; University of Sydney, Sydney, NSW, Australia. Electronic address: karin.chia@health.nsw.gov.au.

Logan Kanagaratnam (L)

Department of Cardiology, Royal North Shore Hospital Sydney, Sydney, NSW, Australia; University of Sydney, Sydney, NSW, Australia; Ryde Hospital, Sydney, NSW, Australia.

Kevin Hellestrand (K)

Department of Cardiology, Royal North Shore Hospital Sydney, Sydney, NSW, Australia; University of Sydney, Sydney, NSW, Australia.

Peter Kowey (P)

Lankenau Heart Institute, Wynnewood, PA, USA; Jefferson Medical College, Philadelphia, PA, USA.

David Whalley (D)

Department of Cardiology, Royal North Shore Hospital Sydney, Sydney, NSW, Australia; University of Sydney, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH